SUBSTITUTED BENZYLAMINES AS CYP2A INHIBITORS AND USES THEREOF TO TREAT NICOTINE DEPENDENCE
申请人:Ghosheh Omar
公开号:US20090137653A1
公开(公告)日:2009-05-28
This invention is directed to substituted benzylamines which are useful as inhibitors of the CYP2A6 enzyme. Pharmaceutical compositions comprising the compounds and methods of using the compounds to treat nicotine dependence are also disclosed.
[EN] SUBSTITUTED BENZYLAMINES AS CYP2A INHIBITORS AND USES THEREOF TO TREAT NICOTINE DEPENDENCE<br/>[FR] BENZYLAMINES SUBSTITUEES SERVANT D'INHIBITEURS DE CYP2A ET UTILISATIONS DE CELLES-CI POUR TRAITER UNE DEPENDANCE A LA NICOTINE
申请人:INFLAZYME PHARM LTD
公开号:WO2006108149A2
公开(公告)日:2006-10-12
[EN] This invention is directed to substitued benzylamines which are useful as inhibitors of the CYP2A6 enzyme. Pharmaceutical compositions comprising the compounds and methods of using the compounds to treat nicotine dependence are also disclosed. [FR] La présente invention concerne des benzylamines substituées qui sont utilisées comme inhibiteurs de l'enzyme CYP2A6, des compositions pharmaceutiques comprenant ces composés et des procédés pour utiliser ces composés afin de traiter une dépendance à la nicotine.